KVUE
Kenvue Inc. (NYSE)
Consumer Defensive — Household & Personal Products
Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine; face and body care, hair, sun, and other care products; oral and baby care, women's health, wound care, and other essential health products; tampons; cosmetics; and vitamins and supplements. It sells its products under the Benadryl, Calpol, Motrin, Nicorette, Rhinocort, Tylenol, Zarbee's Naturals, and Zyrtec; Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Neutrogena, OGX, and Rogaine; BAND-AID, Carefree, Desitin, Johnson's, Listerine, o.b., and Stayfree; and ORSL, Clean & Clear, Versalie, Benylin, Daktarin, Imodium, Johnson's Baby, Johnson's Adult, Maui Moisture, Microlax, Motilium, Neosporin, Neostrata, Pepcid, Pulmicort, Regaine, Sudafed, and Visine/Vispring/Visclear brands. Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey.
Price History
Fundamentals
| Market Cap | $37.11B |
| P/E Ratio (TTM) | 23.01 |
| Forward P/E | 15.63 |
| EPS (TTM) | $0.84 |
| Dividend Yield | 4.29% |
| Profit Margin | 10.61% |
| Revenue Growth | 4.50% |
| ROE | 15.70% |
| Debt/Equity | 82.98 |
| Recommendation | Hold 2.8 |
| Analyst Target | $19.50 |
| Analysts | 12 |
| Indexes | NYSE |
Technical Indicators
| RSI (14) | 73.2 |
| Beta | 0.50 |
| SMA 20 | - |
| SMA 40 | - |
| 52-Week High | $22.87 |
| 52-Week Low | $14.02 |
| 50-Day Avg | $17.73 |
| 200-Day Avg | $17.26 |
| Avg Volume | $20.22M |
| Volume | $14.37M |
Performance Analysis
NEUTRALKVUE presents a mixed picture with both positive and negative indicators.
Recent News
Last updated: Jul 02, 2026 13:17 UTC
Back to Screener Export Report